90 related articles for article (PubMed ID: 29073298)
1. Polycystic ovary syndrome and diabetes mellitus type 1 in adult and adolescent females.
Przygocka-Pieniążek A; Myśliwiec M; Korzeniowska K
Pediatr Endocrinol Diabetes Metab; 2016; 22(4):156-162. PubMed ID: 29073298
[TBL] [Abstract][Full Text] [Related]
2. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Prepubertal Onset of Type 1 Diabetes and Age of Menarche on Polycystic Ovary Syndrome Diagnosis.
Łebkowska A; Adamska A; Krentowska A; Uruska A; Rogowicz-Frontczak A; Araszkiewicz A; Ożegowska K; Hryniewicka J; Leśniewska M; Wender-Ożegowska E; Zozulińska-Ziółkiewicz D; Kowalska I
J Clin Endocrinol Metab; 2021 May; 106(6):1811-1820. PubMed ID: 33537700
[TBL] [Abstract][Full Text] [Related]
4. Hyperandrogenism in adolescent girls with type 1 diabetes mellitus treated with intensive and continuous subcutaneous insulin therapy.
Zachurzok A; Deja G; Gawlik A; Drosdzol-Cop A; Małecka-Tendera E
Endokrynol Pol; 2013; 64(2):121-8. PubMed ID: 23653275
[TBL] [Abstract][Full Text] [Related]
5. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic features of polycystic ovary syndrome in adolescents (review).
Beltadze K; Barbakadze L
Georgian Med News; 2015 Jan; (238):32-4. PubMed ID: 25693210
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
Sirmans SM; Parish RC; Blake S; Wang X
J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
[TBL] [Abstract][Full Text] [Related]
8. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
10. Reproductive disturbances among Saudi adolescent girls and young women with type 1 diabetes mellitus.
Braham R; Robert AA; Musallam MA; Alanazi A; Swedan NB; Al Dawish MA
World J Diabetes; 2017 Nov; 8(11):475-483. PubMed ID: 29204256
[TBL] [Abstract][Full Text] [Related]
11. Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS).
Ashrafi M; Sheikhan F; Arabipoor A; Hosseini R; Nourbakhsh F; Zolfaghari Z
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():195-9. PubMed ID: 25150960
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome in Iranian adolescents.
Esmaeilzadeh S; Delavar MA; Amiri M; Khafri S; Pasha NG
Int J Adolesc Med Health; 2014; 26(4):559-65. PubMed ID: 24447981
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus.
Codner E; Soto N; Lopez P; Trejo L; Avila A; Eyzaguirre FC; Iniguez G; Cassorla F
J Clin Endocrinol Metab; 2006 Jun; 91(6):2250-6. PubMed ID: 16569737
[TBL] [Abstract][Full Text] [Related]
14. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
[TBL] [Abstract][Full Text] [Related]
16. Excess mortality in mothers of patients with polycystic ovary syndrome.
Louwers YV; Roest-Schalken ME; Kleefstra N; Roeters van Lennep J; van den Berg M; Fauser BC; Bilo HJ; Sijbrands EJ; Laven JS
Hum Reprod; 2014 Aug; 29(8):1780-6. PubMed ID: 24876175
[TBL] [Abstract][Full Text] [Related]
17. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
18. Utility of ultrasound in the diagnosis of polycystic ovary syndrome in adolescents.
Youngster M; Ward VL; Blood EA; Barnewolt CE; Emans SJ; Divasta AD
Fertil Steril; 2014 Nov; 102(5):1432-8. PubMed ID: 25226858
[TBL] [Abstract][Full Text] [Related]
19. Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome.
Zhao X; Zhong J; Mo Y; Chen X; Chen Y; Yang D
Int J Gynaecol Obstet; 2010 Feb; 108(2):148-51. PubMed ID: 19932893
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?
Sim SY; Chin SL; Tan JL; Brown SJ; Cussons AJ; Stuckey BG
Fertil Steril; 2016 Oct; 106(5):1258-1263. PubMed ID: 27456547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
